A documentary about Elizabeth Holmes is challenging a comic-book film for the top spot at North American theaters, an unusual contest that gives nonfiction filmmaking a prominent place in Hollywood’s Halloween weekend. Saturday’s box-office reports put A24’s “You Can See Everything” narrowly ahead of Warner Bros. and DC’s “Clayface,” although the full weekend result remains unsettled.
The documentary collected about $3.57 million Friday from 3,243 theaters, according to The Numbers. “Clayface” followed with approximately $3.25 million. The data service projected a weekend near $11 million for the documentary, compared with roughly $10.5 million for the horror film.
Those projections are estimates, not completed sales. TheWrap reported a slightly tighter forecast: $10.6 million for “You Can See Everything” and $10.2 million for “Clayface.” Both assessments point toward a close race that can still change as Saturday and Sunday audiences turn out.
A documentary reaches a broad audience
Directed by Nathan Fielder and Lance Oppenheim, “You Can See Everything” opened Oct. 16. A24 describes its starting point as Holmes inviting a skeptical camera crew to follow her shortly before she goes to prison. The distributor presents the resulting film as a project that developed across three years, rather than a conventional retrospective assembled around the already familiar Theranos story.
The film’s commercial trajectory is more concrete than any claim about why people are watching. Its opening release occupied 855 theaters; the current footprint is nearly four times as large. That expansion establishes that its audience extends beyond a small initial theatrical engagement. It does not, by itself, reveal viewers’ motivations, their age or whether online attention caused them to buy tickets.
The film’s ledger records $56.85 million in domestic receipts through Friday. That is an accumulated theatrical gross, not money retained entirely by the distributor and not a measure of profit. The distinction matters whenever an unexpectedly strong release is described as a financial success.
The next test is staying power
Last weekend’s preliminary reporting already indicated that the documentary was competing well beyond the normal confines of nonfiction releases. The Associated Press reported that “Clayface” opened with an estimated $24 million while the documentary expanded into 2,655 theaters and remained a major commercial story. AP also described growing awards interest around the film, a separate question from its ticket sales.
Saturday’s figures extend that story: the documentary has gained more locations and is now contending for a weekend lead in its third frame. The outcome would be notable even in a relatively quiet marketplace. But a higher chart position should not be mistaken for accelerating revenue. A film can reach first place while its own sales decline, provided competing releases decline more sharply.
That is the pattern suggested here. Both TheWrap and The Numbers forecast lower weekend receipts for the two leaders than in their previous weekends. The documentary’s relative strength is its ability to remain competitive after its initial launch, rather than a claim that every new day is setting a larger record.
Halloween complicates the forecast
Halloween falls on Saturday this year, placing parties and trick-or-treating on a central moviegoing night. The Numbers used earlier Saturday-Halloween weekends in developing its model, while TheWrap described a release calendar without a major new contender displacing the holdovers. That combination makes this weekend a particular test of scheduling as well as demand.
The data service’s Saturday update was more optimistic than its Friday forecast. Such revisions are a useful reminder of the limits of early box-office predictions. Actual Friday receipts can improve the estimate, but they cannot establish precisely how families, horror audiences or documentary viewers will distribute their attendance across the remaining days.
The close gap also argues for patience in ranking the films. The two forecasts differ by only a few hundred thousand dollars between first and second place. Small changes in turnout or subsequent distributor updates could therefore alter the order without changing the larger picture of a competitive weekend.
What the figures can and cannot show
“Clayface” and “You Can See Everything” occupy different creative categories, yet they are competing for the same immediate measure: ticket revenue. Their close positioning demonstrates that an established fictional property does not automatically dominate a nonfiction release. It does not establish a permanent change in audience preferences, or show that the documentary’s subject matter offers a repeatable formula for other filmmakers.
Nor does a weekend forecast settle an awards race. Strong attendance can give a film greater visibility, but commercial performance and artistic recognition remain separate outcomes. For theaters and distributors, the immediate evidence is that this documentary has sustained enough demand to support a substantial expansion.
The decisive numbers will come after the weekend. Until then, the defensible conclusion is narrower than a victory declaration: “You Can See Everything” led Friday sales, has accumulated a sizable theatrical audience and is positioned to challenge “Clayface” for first place. A documentary has earned a place at the center of the box-office conversation without the final result yet being known.
